The company was supposed to perform heart monitoring services in the U.S., and BioTelemetry faces allegations that clinicians in India were not properly certified in performing the monitoring, according to a Dec. 21 news release from law firm Ross Feller Casey.
Fewer than 3 percent of the technicians who reviewed the data of the U.S. Medicare patients were properly certified, the release said.
The fraud allegations came to light through a whistleblower lawsuit brought against the company by Ross Feller Casey on behalf of former employees.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
